Correlation Between Mosaic Immunoengineerin and PhaseBio Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Mosaic Immunoengineerin and PhaseBio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mosaic Immunoengineerin and PhaseBio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mosaic Immunoengineering and PhaseBio Pharmaceuticals, you can compare the effects of market volatilities on Mosaic Immunoengineerin and PhaseBio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mosaic Immunoengineerin with a short position of PhaseBio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mosaic Immunoengineerin and PhaseBio Pharmaceuticals.
Diversification Opportunities for Mosaic Immunoengineerin and PhaseBio Pharmaceuticals
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between Mosaic and PhaseBio is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Mosaic Immunoengineering and PhaseBio Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PhaseBio Pharmaceuticals and Mosaic Immunoengineerin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mosaic Immunoengineering are associated (or correlated) with PhaseBio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PhaseBio Pharmaceuticals has no effect on the direction of Mosaic Immunoengineerin i.e., Mosaic Immunoengineerin and PhaseBio Pharmaceuticals go up and down completely randomly.
Pair Corralation between Mosaic Immunoengineerin and PhaseBio Pharmaceuticals
If you would invest 51.00 in Mosaic Immunoengineering on September 2, 2024 and sell it today you would earn a total of 49.00 from holding Mosaic Immunoengineering or generate 96.08% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 0.4% |
| Values | Daily Returns |
Mosaic Immunoengineering vs. PhaseBio Pharmaceuticals
Performance |
| Timeline |
| Mosaic Immunoengineering |
| PhaseBio Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Mosaic Immunoengineerin and PhaseBio Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mosaic Immunoengineerin and PhaseBio Pharmaceuticals
The main advantage of trading using opposite Mosaic Immunoengineerin and PhaseBio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mosaic Immunoengineerin position performs unexpectedly, PhaseBio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PhaseBio Pharmaceuticals will offset losses from the drop in PhaseBio Pharmaceuticals' long position.| Mosaic Immunoengineerin vs. Cell Source | Mosaic Immunoengineerin vs. Marizyme | Mosaic Immunoengineerin vs. ACRO Biomedical Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges |